Opioids and fibromyalgia: frequency of use and factors associated with increased consumption in patients remitted to a tertiary care center

Abstract Background Opioids are not recommended for fibromyalgia. Objective To investigate the frequency of opioid use in a large cohort of fibromyalgia patients and to identify factors associated with opioid consumption. Methods A retrospective, observational study of a large fibromyalgia cohort in...

Full description

Bibliographic Details
Main Authors: Javier Rivera, Juan Molina-Collada, Julia Martínez-Barrio, Belén Serrano-Benavente, Isabel Castrejón, Miguel A. Vallejo, Jose María Álvaro-Gracia
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Musculoskeletal Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12891-024-07263-x
_version_ 1797276165092671488
author Javier Rivera
Juan Molina-Collada
Julia Martínez-Barrio
Belén Serrano-Benavente
Isabel Castrejón
Miguel A. Vallejo
Jose María Álvaro-Gracia
author_facet Javier Rivera
Juan Molina-Collada
Julia Martínez-Barrio
Belén Serrano-Benavente
Isabel Castrejón
Miguel A. Vallejo
Jose María Álvaro-Gracia
author_sort Javier Rivera
collection DOAJ
description Abstract Background Opioids are not recommended for fibromyalgia. Objective To investigate the frequency of opioid use in a large cohort of fibromyalgia patients and to identify factors associated with opioid consumption. Methods A retrospective, observational study of a large fibromyalgia cohort in a tertiary care center. We assessed fibromyalgia severity, functional capacity, anxiety, depression, drugs consumption and the patient’s impression of change. We compared strong opioid consumers (SOC) and non-SOC. Inferential statistical and logistic regression analysis were used to identify factors associated with opioid consumption, and ANOVA for repeated measurements. Results We found a prevalence of 9.2% of SOC (100 patients) among 1087 patients in the cohort. During the last four years there was a significant increase on the incidence of SOC up to 12.8% (p = 0.004). There were no differences in demographic variables between SOC and non-SOC. Clinical variables were significantly more severe in SOC, and they consumed more non-opioid drugs (p < 0.0001). Opioid consumption was independently associated with other non-opioid drugs (Odds ratio 1.25, CI: 1.13–1.38), but not with the fibromyalgia severity. At three months, 62% of the patients had opioid withdrawal. There were no statistical differences in the fibromyalgia severity at the initial evaluation, or the patient’s impression of change compared with those patients who continued opioids. Coping strategies were better in those patients who withdrew opioids (p = 0.044). Conclusions We observed an increase in opioid prescriptions during the last four years. Opioid consumption was associated with concomitant use of non-opioid drugs, but it was not associated with fibromyalgia severity.
first_indexed 2024-03-07T15:24:26Z
format Article
id doaj.art-00e329ea41a2489ba79a5bb1106231ec
institution Directory Open Access Journal
issn 1471-2474
language English
last_indexed 2024-03-07T15:24:26Z
publishDate 2024-02-01
publisher BMC
record_format Article
series BMC Musculoskeletal Disorders
spelling doaj.art-00e329ea41a2489ba79a5bb1106231ec2024-03-05T17:23:53ZengBMCBMC Musculoskeletal Disorders1471-24742024-02-012511810.1186/s12891-024-07263-xOpioids and fibromyalgia: frequency of use and factors associated with increased consumption in patients remitted to a tertiary care centerJavier Rivera0Juan Molina-Collada1Julia Martínez-Barrio2Belén Serrano-Benavente3Isabel Castrejón4Miguel A. Vallejo5Jose María Álvaro-Gracia6Rheumatology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)Rheumatology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)Rheumatology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)Rheumatology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)Rheumatology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)Department of Clinical Psychology, Universidad Nacional de Educación a Distancia (UNED)Rheumatology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)Abstract Background Opioids are not recommended for fibromyalgia. Objective To investigate the frequency of opioid use in a large cohort of fibromyalgia patients and to identify factors associated with opioid consumption. Methods A retrospective, observational study of a large fibromyalgia cohort in a tertiary care center. We assessed fibromyalgia severity, functional capacity, anxiety, depression, drugs consumption and the patient’s impression of change. We compared strong opioid consumers (SOC) and non-SOC. Inferential statistical and logistic regression analysis were used to identify factors associated with opioid consumption, and ANOVA for repeated measurements. Results We found a prevalence of 9.2% of SOC (100 patients) among 1087 patients in the cohort. During the last four years there was a significant increase on the incidence of SOC up to 12.8% (p = 0.004). There were no differences in demographic variables between SOC and non-SOC. Clinical variables were significantly more severe in SOC, and they consumed more non-opioid drugs (p < 0.0001). Opioid consumption was independently associated with other non-opioid drugs (Odds ratio 1.25, CI: 1.13–1.38), but not with the fibromyalgia severity. At three months, 62% of the patients had opioid withdrawal. There were no statistical differences in the fibromyalgia severity at the initial evaluation, or the patient’s impression of change compared with those patients who continued opioids. Coping strategies were better in those patients who withdrew opioids (p = 0.044). Conclusions We observed an increase in opioid prescriptions during the last four years. Opioid consumption was associated with concomitant use of non-opioid drugs, but it was not associated with fibromyalgia severity.https://doi.org/10.1186/s12891-024-07263-xFibromyalgiaTreatmentDrug therapyOpioidsRheumatic diseases
spellingShingle Javier Rivera
Juan Molina-Collada
Julia Martínez-Barrio
Belén Serrano-Benavente
Isabel Castrejón
Miguel A. Vallejo
Jose María Álvaro-Gracia
Opioids and fibromyalgia: frequency of use and factors associated with increased consumption in patients remitted to a tertiary care center
BMC Musculoskeletal Disorders
Fibromyalgia
Treatment
Drug therapy
Opioids
Rheumatic diseases
title Opioids and fibromyalgia: frequency of use and factors associated with increased consumption in patients remitted to a tertiary care center
title_full Opioids and fibromyalgia: frequency of use and factors associated with increased consumption in patients remitted to a tertiary care center
title_fullStr Opioids and fibromyalgia: frequency of use and factors associated with increased consumption in patients remitted to a tertiary care center
title_full_unstemmed Opioids and fibromyalgia: frequency of use and factors associated with increased consumption in patients remitted to a tertiary care center
title_short Opioids and fibromyalgia: frequency of use and factors associated with increased consumption in patients remitted to a tertiary care center
title_sort opioids and fibromyalgia frequency of use and factors associated with increased consumption in patients remitted to a tertiary care center
topic Fibromyalgia
Treatment
Drug therapy
Opioids
Rheumatic diseases
url https://doi.org/10.1186/s12891-024-07263-x
work_keys_str_mv AT javierrivera opioidsandfibromyalgiafrequencyofuseandfactorsassociatedwithincreasedconsumptioninpatientsremittedtoatertiarycarecenter
AT juanmolinacollada opioidsandfibromyalgiafrequencyofuseandfactorsassociatedwithincreasedconsumptioninpatientsremittedtoatertiarycarecenter
AT juliamartinezbarrio opioidsandfibromyalgiafrequencyofuseandfactorsassociatedwithincreasedconsumptioninpatientsremittedtoatertiarycarecenter
AT belenserranobenavente opioidsandfibromyalgiafrequencyofuseandfactorsassociatedwithincreasedconsumptioninpatientsremittedtoatertiarycarecenter
AT isabelcastrejon opioidsandfibromyalgiafrequencyofuseandfactorsassociatedwithincreasedconsumptioninpatientsremittedtoatertiarycarecenter
AT miguelavallejo opioidsandfibromyalgiafrequencyofuseandfactorsassociatedwithincreasedconsumptioninpatientsremittedtoatertiarycarecenter
AT josemariaalvarogracia opioidsandfibromyalgiafrequencyofuseandfactorsassociatedwithincreasedconsumptioninpatientsremittedtoatertiarycarecenter